Dr. Krishna M Ella

Executive Chairman, Bharat Biotech

Under his leadership, Bharat Biotech has risen into a global leader in vaccine innovation.As a serial entrepreneur, he has diversified Bharat Biotech Group into veterinary health, food processing and biotechnology infrastructure, while actively contributing to India’s science education and policy through his association with committees like the Scientific Advisory Committee to the Union Cabinet.

Achievements & Recognition

  • Padma Bhushan awardee.

  • Pioneer behind COVAXIN, iNCOVACC, ROTAVAC and Typbar TCV with 220+ patents and over 9 billion doses delivered worldwide.

  • Leads Bharat Biotech, Biovet and Ella Foods; driving India’s cell and gene therapy, biotech parks, and global vaccine innovation.

Skegen

Svadha Capital Trust | SEBI registration number: IN/AIF2/23-24/1278 | Category II AIF | Investment Manager: Skegen Asset Management LLP

© 2026 – SKEGEN – All rights reserved

Svadha Capital Trust | SEBI registration number: IN/AIF2/23-24/1278 | Category II AIF | Investment Manager: Skegen Asset Management LLP

© 2026 – SKEGEN – All rights reserved

Svadha Capital Trust | SEBI registration number: IN/AIF2/23-24/1278 | Category II AIF | Investment Manager: Skegen Asset Management LLP

© 2026 – SKEGEN – All rights reserved